Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KYTHERA BIOPHARMACEUTICALS INC (KYTH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09
   10-K10-K10-K10-K10-K/AS-1/A
Revenues   [+]132.450.519.713.04.529.5
            Revenue growth  162.3%156.4%51.6%189.3%-84.8% 
Cost of goods sold  0.00.01.91.20.414.8
Gross profit  132.450.517.811.84.114.8
            Gross margin  100.0%100.0%90.2%90.9%90.8%50.0%
Selling, general and administrative   [+]31.116.110.56.96.84.9
Research and development  47.834.043.215.814.89.8
Other operating expenses  132.450.5   14.8
EBITDA   [+]-78.6-49.8-35.3-10.8-17.4146.2
            EBITDA margin  -59.4%-98.7%-179.3%-83.1%-387.2%495.7%
Depreciation and amortization  0.30.20.60.10.2161.0
EBIT   [+]-78.9-50.1-35.9-10.8-17.6-14.8
            EBIT margin  -59.6%-99.2%-182.5%-83.5%-391.0%-50.0%
Non-recurring items   [+]52.8     
Interest expense, net   [+]3.91.80.40.1  
Other income (expense), net   [+]-0.1 -0.4-0.21.50.0
Pre-tax income  -135.6-51.9-36.8-11.2-16.0-14.8
Income taxes  0.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -135.6-51.9-36.8-11.2-16.0-14.8
            Net margin  -102.4%-102.8%-186.9%-85.9%-357.2%-50.0%
   
Basic EPS   [+]($6.04)($2.71)($7.47)($7.98)($11.64)($10.85)
Diluted EPS   [+]($6.04)($2.71)($7.47)($7.98)($11.64)($10.85)
   
Shares outstanding (basic)   [+]22.519.24.91.41.41.4
Shares outstanding (diluted)   [+]22.519.24.91.41.41.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy